Correspondence clarifying statements made at Melbourne public hearing on 2 November 2018, received from Thalidomide Group Australia, 20 November 2018 (PDF 105KB)
We are committed to ensuring that everyone who wishes to can participate in the Committee’s inquiry. If you have accessibility requirements, please contact the Committee Secretariat.
Further information regarding accessibility can be found at www.aph.gov.au/Help/Accessibility
Senate
House of Representatives
Get informed
Bills
Committees
Get involved
Visit Parliament
Website features
Parliamentary Departments